Tumor Necrosis Factor Receptor Superfamily Member 10C (TNFRSF10C) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Tumor Necrosis Factor Receptor Superfamily Member 10C (TNFRSF10C) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityTumor Necrosis Factor Receptor Superfamily Member 10C (TNFRSF10C)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formataffinity purified
Size20 µl, 50 µl, 100 µl, 200 µl
Concentration> 0.5 mg/ml
ApplicationsWB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionTNFRSF10C Antibody is a Rabbit Polyclonal antibody against TNFRSF10C. The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.
ImmunogenRecombinant protein of human TNFRSF10C.
Other NamesLIT, DCR1, TRID, CD263, TRAILR3, TRAIL-R3, DCR1-TNFR, Tumor necrosis factor receptor superfamily member 10C, Antagonist decoy receptor for TRAIL/Apo-2L, Decoy TRAIL receptor without death domain, Decoy receptor 1, Lymphocyte inhibitor of TRAIL, TNF-related apoptosis-inducing ligand receptor 3, TRAIL receptor 3, TRAIL receptor without an intracellular domain, TNFRSF10C, UNQ321/PRO366, LIT, LIT, LIT, LIT, DCR1, DCR1, DCR1, DCR1, TRID, TRID, TRID, TRID, CD263, CD263, CD263, CD263, TRAILR3, TRAILR3, TRAILR3, TRAILR3, TRAIL-R3, TRAIL-R3, TRAIL-R3, TRAIL-R3, DCR1-TNFR, DCR1-TNFR, DCR1-TNFR, DCR1-TNFR, Tumor necrosis factor receptor superfamily member 10C, Tumor necrosis factor receptor superfamily member 10C, Tumor necrosis factor receptor superfamily member 10C, Tumor necrosis factor receptor superfamily member 10C, Antagonist decoy receptor for TRAIL/Apo-2L, Antagonist decoy receptor for TRAIL/Apo-2L, Antagonist decoy receptor for TRAIL/Apo-2L, Antagonist decoy receptor for TRAIL/Apo-2L, Decoy TRAIL receptor without death domain, Decoy TRAIL receptor without death domain, Decoy TRAIL receptor without death domain, Decoy TRAIL receptor without death domain, Decoy receptor 1, Decoy receptor 1, Decoy receptor 1, Decoy receptor 1, Lymphocyte inhibitor of TRAIL, Lymphocyte inhibitor of TRAIL, Lymphocyte inhibitor of TRAIL, Lymphocyte inhibitor of TRAIL, TNF-related apoptosis-inducing ligand receptor 3, TNF-related apoptosis-inducing ligand receptor 3, TNF-related apoptosis-inducing ligand receptor 3, TNF-related apoptosis-inducing ligand receptor 3, TRAIL receptor 3, TRAIL receptor 3, TRAIL receptor 3, TRAIL receptor 3, TRAIL receptor without an intracellular domain, TRAIL receptor without an intracellular domain, TRAIL receptor without an intracellular domain, TRAIL receptor without an intracellular domain, TNFRSF10C, TNFRSF10C, TNFRSF10C, TNFRSF10C, UNQ321/PRO366, UNQ321/PRO366, UNQ321/PRO366, UNQ321/PRO366
Gene, Accession #TNFRSF10C, Gene ID: 8794, UniProt: O14798
Catalog #abx001051
Priceplease inquire
Order / More InfoTumor Necrosis Factor Receptor Superfamily Member 10C (TNFRSF10C) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.